Incidence and Risk Factors of Recipient Surgical Site Infection in Oral and Maxillofacial Reconstruction with Vascularized Fibular Bone Grafts
DOI:
https://doi.org/10.31584/jhsmr.2020742Keywords:
risk factor, surgical site infection, vascularized fibular bone graftAbstract
Objective: To determine the incidence and risk factors of recipient surgical site infection (RSSI) after oral and maxillofacial reconstruction with vascularized fibular bone grafts (VFBG).
Material and Methods: This retrospective study was performed in patients who underwent oral and maxillofacial reconstructive surgery, with VFBG, at the Dental Hospital, Faculty of Dentistry, Prince of Songkla University. Demographic, preoperative, intraoperative and postoperative data were recorded. Any infection at the recipient site occurring within 30 days post-operatively, by criteria from the Center of Disease Control, was defined as RSSI. Statistical analysis was performed by chi-square test, Student's t-test and Pearson’s correlation coefficient with statistical significance was set at 0.05.
Results: There were twenty-one patients who met the eligibility criteria. The incidence of RSSI after oral and maxillofacial reconstruction with VFBG was 47.6% (10/21 patients), and the success rate of VFBG was 95.2%. American Society of Anesthetics (ASA) physical status class II and oral contamination were significant risk factors for RSSI (p-value=0.004 and p-value=0.031, respectively). Length of hospital stay was significantly higher in the RSSI group (p-value<0.001).
Conclusion: The incidence of RSSI after oral and maxillofacial reconstruction with VFBG was high, and ASA physical status class II and oral contamination were significant risk factors for RSSI.
References
O’Leary MJ, Martin PJ, Hayden RE. The neurocutaneous free fibula flap in mandibular reconstruction. Otolaryngol Clin North Am 1994;27:1081-96.
Urken ML. Composite free flaps in oromandibular reconstruction. Arch Otolaryngol Head Neck Surg 1991;117:724-32.
Urken ML, Weinberg H, Buchbinder D, Moscoso JF, Lawson W, Catalano PJ, et al. Microvascular free flaps in head and neck reconstruction. report of 200 cases and review of complications. Arch Otolaryngol Head Neck Surg 1994;120: 633-40.
Ogihara H, Takeuchi K, Majima Y. Risk factors of postoperative infection in head and neck surgery. Auris Nasus Larynx 2009; 36:457-60.
Lee DH, Kim SY, Nam SY, Choi SH, Choi JW, Roh JL. Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer. Oral Oncol 2011;47:528-31.
Yang CH, Chew KY, Solomkin JS, Lin PY, Chiang YC, Kuo YR. Surgical site infections among high-risk patients in cleancontaminated head and neck reconstructive surgery: concordance with preoperative oral flora. Ann Plast Surg 2013; 71(Suppl 1):S55-60.
Karakida K, Aoki T, Ota Y, Yamazaki H, Otsuru M, Takahashi M, et al. Analysis of risk factors for surgical-site infections in 276 oral cancer surgeries with microvascular free-flap reconstructions at a single university hospital. J Infect Chemother 2010;16:334-9.
Eder-Czembirek C, Czembirek C, Braun P, Perisanidis C, Seemann R. Surgical site infection in clean-contaminated wounds after multimodal treatment of advanced oral squamous cell carcinoma. J Craniomaxillofac Surg 2016;44:1957-62.
Murphy J, Isaiah A, Dyalram D, Lubek JE. Surgical site infections in patients receiving osteomyocutaneous free faps to the head and neck. Does choice of antibiotic prophylaxis matter? J Oral Maxillofac Surg 2017;75:2223-9.
Cannon RB, Houlton JJ, Mendez E, Futran ND. Methods to reduce postoperative surgical site infections after head and neck oncology surgery. Lancet Oncol 2017;18:e405-13.
Candau-Alvarez A, Linares-Sicilia MJ, Dean-Ferrer A, Pérez- Navero JL. Role of culture of postoperative drainage fluid in the prediction of infection of the surgical site after major oncological operations of the head and neck. Br J Oral Maxillofac Surg 2015;53:200-3.
Wilson D, Wakefield M, Owen N, Roberts L. Characteristics of heavy smokers. Prev Med 1992;21:311-9.
CDC.gov. Alcohol use and your health [homepage on the Internet]. Atlanta: Centers for Disease Control and Prevention [cited 2020 Mar 10]. Available from: https://www.cdc.gov/ alcohol/fact-sheets/alcohol-use.htm
Jewer DD, Boyd JB, Manktelow RT, Zuker RM, Rosen IB, Gullane PJ, et al. Orofacial and mandibular reconstruction with the iliac crest free flap: a review of 60 cases and a new method of classification. Plast Reconstr Surg 1989;84:391- 403.
Brown JS, Rogers SN, McNally DN, Boyle M. A modified classification for the maxillectomy defect. Head Neck 2000; 22:17-26.
Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-78.
Penel N, Fournier C, Lefebvre D, Lefebvre JL. Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa. Study of 260 surgical procedures. Oral Oncol 2005; 41:294–303.
Lotfi CJ, Cavalcanti Rde C, Costa e Silva AM, Latorre Mdo R, Ribeiro Kde C, Carvalho AL, et al. Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg 2008;138:74–80.
Penel N, Mallet Y, Roussel-Delvallez M, Lefebvre JL, Yazdanpanah Y. Factors determining length of the postoperative hospital stay after major head and neck cancer surgery. Oral Oncol 2008;44:555-62.
Liu SA, Wong YK, Poon CK, Wang CC, Wang CP, Tung KC. Risk factors for wound infection after surgery in primary oral cavity cancer patients. Laryngoscope 2007;117:166–71.
Lahtinen S, Koivunen P, Ala-Kokko T, Kaarela O, Ohtonen P, Laurila P, Liisanantti JH. Complications and outcome after free flap surgery for cancer of the head and neck. Br J Oral Maxillofac Surg 2018;56:684-91.
Robbins KT, Byers RM, Cole R, Fainstein V, Guillamondegui OM, Schantz SP, et al. Wound prophylaxis with metronidazole in head and neck surgical oncology. Laryngoscope 1988;98: 803-6.
Johnson JT, Yu VL. Antibiotic use during major head and neck surgery. Ann Surg 1988;207:108-11.
Veve MP, Davis SL, Williams AM, McKinnon JE, Ghanem TA. Considerations for antibiotic prophylaxis in head and neck cancer surgery. Oral Oncol 2017;74:181-7.
Chiesa-Estomba CM, Lechien JR, Fakhry N, Melkane A, Calvo-Henriquez C, de Siati D, et al. Systematic review of international guidelines for perioperative antibiotic prophylaxis in Head & Neck Surgery. A YO-IFOS Head & Neck Study Group Position Paper. Head Neck 2019;41:3434-56.
Kainulainen S, Törnwall J, Koivusalo AM, Suominen AL, Lassus P. Dexamethasone in head and neck cancer patients with microvascular reconstruction: no benefit, more complications. Oral Oncol 2017;65:45-50.
Zhou W, Zhang WB, Yu Y, Wang Y, Mao C, Guo CB, et al. Risk factors for free flap failure: a retrospective analysis of 881 free flaps for head and neck defect reconstruction. Int J Oral Maxillofac Surg 2017;46:941-5.
Benatar MJ, Dassonville O, Chamorey E, Poissonnet G, Ettaiche M, Pierre CS, et al. Impact of preoperative radiotherapy on head and neck free flap reconstruction: a report on 429 cases. J Plast Reconstr Aesthet Surg 2013;66:478-82.
Rosman M, Rachminov O, Segal O, Segal G. Prolonged patients' in-hospital waiting period after discharge eligibility is associated with increased risk of infection, morbidity and mortality: a retrospective cohort analysis. BMC Health Serv Res 2015;15:246.
Downloads
Published
How to Cite
Issue
Section
